Clinical trial
The Effect of Danzhu Fuyuan Granule as Adjunctive Therapy for Chronic Stable Angina, Vascular Dementia and Idiopathic Membranous Nephropathy: A Bayesian Basket Trial
NCT04498962 is registered in ClinicalTrials.gov with Jingqing Hu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Danzhu Fuyuan Granule as Adjunctive Therapy for Chronic Stable Angina, Vascular Dementia and Idiopathic Membranous Nephropathy: A Bayesian Basket Trial
- Lead sponsor
- Jingqing Hu
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 31, 2020
- Completion date
- December 1, 2021
- Enrollment
- 240 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
chronic stable angina, idiopathic membranous nephropathy, vascular dementia